Therapeutic Category
- Antineoplastic Agent, BCR-ABL Tyrosine Kinase Inhibitor
- Antineoplastic Agent, Tyrosine Kinase Inhibitor
Medication Safety Issues
Sound-alike/look-alike issues:
Imatinib may be confused with asciminib, avapritinib, axitinib, bosutinib, cabozantinib, capmatinib, dasatinib, enasidenib, erlotinib, fostamatinib, gefitinib, ibrutinib, idelalisib, infigratinib, ivosidenib, lapatinib, neratinib, nilotinib, PONATinib, regorafenib, ripretinib, SUNItinib
High alert medication:
This medication is in a class the Institute for Safe Medication Practices (ISMP) includes among its list of drug classes which have a heightened risk of causing significant patient harm when used in error.